About Emalex Biosciences
Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Chicago, United States
Year Founded
2018
Team Size
51–100 employees
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
emalexbiosciences.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@ParagonBiosci
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $250,000,000 · Series-B
Backed by Bain Capital Life Sciences
- Capital Raise
Raised $35,000,000 · Series-B
Backed by Paragon Biosciences
- Milestone
Company founded
Chicago, United States
Investors & Backers
Bain Capital Life Sciences
Lead
Paragon Biosciences
Lead
Fidelity
Horizon Technology Finance
Valor Equity Partners
Funding History
Series-B equity
· Nov 3, 2022
Round backers: Bain Capital Life Sciences
$250,000,000 fundraisingfox.com
Series-B equity
· Mar 23, 2021
Round backers: Paragon Biosciences
$35,000,000 finsmes.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026